Register for email alerts and news feeds:
This journal | BMJ Group
rss
Tobacco Control 2005;14(Supplement 2 ):ii3-ii7; doi:10.1136/tc.2004.008334
Copyright © 2005 by the BMJ Publishing Group Ltd.

RESEARCH PAPER

"Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product

L T Kozlowski, B Q Edwards

Department of Biobehavioral Health, The Pennsylvania State University, Pennsylvania, USA

Correspondence to:
Correspondence to:
Professor Lynn T Kozlowski
Department of Biobehavioral Health, Penn State, 315 East Health and Human Development, University Park, PA 16802, USA; ltk1{at}psu.edu

The right to health relevant information derives from the principles of autonomy and self direction and has been recognised in international declarations. Providing accurate health information is part of the basis for obtaining "informed consent" and is a recognised component of business ethics, safety communications, and case and product liability law. Remarkably, anti-tobacco and pro-tobacco sources alike have come to emphasise the message that there is "no safe cigarette" or "no safe tobacco product". We propose that the "no safe" message is so limited in its value that it represents a violation of the right to health relevant information. There is a need to go beyond saying, "there is no safe tobacco product" to indicate information on degree of risks. The "no safe tobacco" message does not contradict, for example, the mistaken belief that so called light or low tar cigarettes are safer choices than higher tar cigarettes. We encourage a kind of "rule utilitarian" ethical position in which the principle of truth telling is observed while trying to produce the greatest good for the greatest number of people. Although harm reduction approaches to easing the burden of tobacco related diseases are founded on science based comparative risk information, the right to health information is independently related to the need to promote health literacy. This right should be respected whether or not harm reduction policies are judged advisable.

Abbreviations: CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; FTC, Federal Trade Commission; NCI, National Cancer Institute; NIA, National Institute on Aging; PM, Philip Morris; SARS, severe acute respiratory syndrome

Keywords: ethics; harm reduction; health communication; rights


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Biener, L., Bogen, K. (2009). Receptivity to Taboka and Camel Snus in a U.S. test market. Nicotine Tob Res 11: 1154-1159 [Abstract] [Full Text]  
  • Kozlowski, L. T (2008). The proposed tobacco regulation: the triumph of hope over experience?. Tobacco Control 17: 74-75 [Full Text]  
  • Phillips, C. V (2008). Commentary: Lack of scientific influences on epidemiology. Int J Epidemiol 37: 59-64 [Full Text]  
  • Katz, J E (2005). Individual rights advocacy in tobacco control policies: an assessment and recommendation. Tobacco Control 14: ii31-ii37 [Abstract] [Full Text]  

eLetters:

Read all eLetters

Scientific buffoonery
Kevin M. Mulvina, et al.
Tobacco Control Online, 15 Mar 2006 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.